Shannon Thyme Klinger - 27 Aug 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Legal Officer
Signature
/s/ James Dillon, as Attorney-in-Fact
Issuer symbol
MRNA
Transactions as of
27 Aug 2025
Transactions value $
-$13,290
Form type
4
Filing time
29 Aug 2025, 16:10:00
Previous filing
09 Jun 2025
Next filing
02 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Klinger Shannon Thyme Chief Legal Officer C/O MODERNA, INC., 325 BINNEY STREET, CAMBRIDGE /s/ James Dillon, as Attorney-in-Fact 2025-08-29 0001866132

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise +774 +2.82% 28.3K 27 Aug 2025 Direct F1
transaction MRNA Common Stock Tax liability -$9.27K -375 -1.33% $24.73 27.9K 27 Aug 2025 Direct F2
transaction MRNA Common Stock Options Exercise +329 +1.18% 28.2K 28 Aug 2025 Direct F1
transaction MRNA Common Stock Tax liability -$4.02K -160 -0.57% $25.10 28.1K 28 Aug 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Restricted Stock Units Options Exercise $0 -774 -9.1% $0.00 7.74K 27 Aug 2025 Common Stock 774 Direct F1, F3
transaction MRNA Restricted Stock Units Options Exercise $0 -329 -14.29% $0.00 1.97K 28 Aug 2025 Common Stock 329 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F4 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.